260 related articles for article (PubMed ID: 23980095)
21. The NSD2/WHSC1/MMSET methyltransferase prevents cellular senescence-associated epigenomic remodeling.
Tanaka H; Igata T; Etoh K; Koga T; Takebayashi SI; Nakao M
Aging Cell; 2020 Jul; 19(7):e13173. PubMed ID: 32573059
[TBL] [Abstract][Full Text] [Related]
22. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
Swaroop A; Oyer JA; Will CM; Huang X; Yu W; Troche C; Bulic M; Durham BH; Wen QJ; Crispino JD; MacKerell AD; Bennett RL; Kelleher NL; Licht JD
Oncogene; 2019 Jan; 38(5):671-686. PubMed ID: 30171259
[TBL] [Abstract][Full Text] [Related]
23. Identification of ID-1 as a potential target gene of MMSET in multiple myeloma.
Hudlebusch HR; Theilgaard-Mönch K; Lodahl M; Johnsen HE; Rasmussen T
Br J Haematol; 2005 Sep; 130(5):700-8. PubMed ID: 16115125
[TBL] [Abstract][Full Text] [Related]
24. Identification of LEM-14 inhibitor of the oncoprotein NSD2.
Shen Y; Morishita M; Lee D; Kim S; Lee T; Mevius DEHF; Roh Y; di Luccio E
Biochem Biophys Res Commun; 2019 Jan; 508(1):102-108. PubMed ID: 30471851
[TBL] [Abstract][Full Text] [Related]
25. A novel functional role for MMSET in RNA processing based on the link between the REIIBP isoform and its interaction with the SMN complex.
Mirabella F; Murison A; Aronson LI; Wardell CP; Thompson AJ; Hanrahan SJ; Fok JH; Pawlyn C; Kaiser MF; Walker BA; Davies FE; Morgan GJ
PLoS One; 2014; 9(6):e99493. PubMed ID: 24923560
[TBL] [Abstract][Full Text] [Related]
26. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
[TBL] [Abstract][Full Text] [Related]
27. Histone methyltransferase NSD2 mediates the survival and invasion of triple-negative breast cancer cells via stimulating ADAM9-EGFR-AKT signaling.
Wang JJ; Zou JX; Wang H; Duan ZJ; Wang HB; Chen P; Liu PQ; Xu JZ; Chen HW
Acta Pharmacol Sin; 2019 Aug; 40(8):1067-1075. PubMed ID: 30670815
[TBL] [Abstract][Full Text] [Related]
28. NSD2 overexpression drives clustered chromatin and transcriptional changes in a subset of insulated domains.
Lhoumaud P; Badri S; Rodriguez-Hernaez J; Sakellaropoulos T; Sethia G; Kloetgen A; Cornwell M; Bhattacharyya S; Ay F; Bonneau R; Tsirigos A; Skok JA
Nat Commun; 2019 Oct; 10(1):4843. PubMed ID: 31649247
[TBL] [Abstract][Full Text] [Related]
29. Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.
Chu L; Su MY; Maggi LB; Lu L; Mullins C; Crosby S; Huang G; Chng WJ; Vij R; Tomasson MH
J Clin Invest; 2012 Aug; 122(8):2793-806. PubMed ID: 22751105
[TBL] [Abstract][Full Text] [Related]
30. A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin.
Sankaran SM; Wilkinson AW; Elias JE; Gozani O
J Biol Chem; 2016 Apr; 291(16):8465-74. PubMed ID: 26912663
[TBL] [Abstract][Full Text] [Related]
31. The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
Lauring J; Abukhdeir AM; Konishi H; Garay JP; Gustin JP; Wang Q; Arceci RJ; Matsui W; Park BH
Blood; 2008 Jan; 111(2):856-64. PubMed ID: 17942756
[TBL] [Abstract][Full Text] [Related]
32. Proteosomal degradation of NSD2 by BRCA1 promotes leukemia cell differentiation.
Park JW; Kang JY; Hahm JY; Kim HJ; Seo SB
Commun Biol; 2020 Aug; 3(1):462. PubMed ID: 32826945
[TBL] [Abstract][Full Text] [Related]
33. A Scalable Platform for Producing Recombinant Nucleosomes with Codified Histone Methyltransferase Substrate Preferences.
McDevitt PJ; Schneck JL; Diaz E; Hou W; Huddleston MJ; Matico RE; McCormick PM; Kirkpatrick RB
Protein Expr Purif; 2019 Dec; 164():105455. PubMed ID: 31306746
[TBL] [Abstract][Full Text] [Related]
34. Backbone resonance assignments for the SET domain of the human methyltransferase NSD2.
Bobby R; Peciak K; Milbradt AG
Biomol NMR Assign; 2016 Oct; 10(2):307-10. PubMed ID: 27368234
[TBL] [Abstract][Full Text] [Related]
35. The MMSET protein is a histone methyltransferase with characteristics of a transcriptional corepressor.
Marango J; Shimoyama M; Nishio H; Meyer JA; Min DJ; Sirulnik A; Martinez-Martinez Y; Chesi M; Bergsagel PL; Zhou MM; Waxman S; Leibovitch BA; Walsh MJ; Licht JD
Blood; 2008 Mar; 111(6):3145-54. PubMed ID: 18156491
[TBL] [Abstract][Full Text] [Related]
36. Unabridged Analysis of Human Histone H3 by Differential Top-Down Mass Spectrometry Reveals Hypermethylated Proteoforms from MMSET/NSD2 Overexpression.
Zheng Y; Fornelli L; Compton PD; Sharma S; Canterbury J; Mullen C; Zabrouskov V; Fellers RT; Thomas PM; Licht JD; Senko MW; Kelleher NL
Mol Cell Proteomics; 2016 Mar; 15(3):776-90. PubMed ID: 26272979
[TBL] [Abstract][Full Text] [Related]
37. NSD2 promotes tumor angiogenesis through methylating and activating STAT3 protein.
Song D; Lan J; Chen Y; Liu A; Wu Q; Zhao C; Feng Y; Wang J; Luo X; Cao Z; Cao X; Hu J; Wang G
Oncogene; 2021 Apr; 40(16):2952-2967. PubMed ID: 33742125
[TBL] [Abstract][Full Text] [Related]
38. S-adenosylhomocysteine (AdoHcy)-dependent methyltransferase inhibitor DZNep overcomes breast cancer tamoxifen resistance via induction of NSD2 degradation and suppression of NSD2-driven redox homeostasis.
Wang Q; Zheng J; Zou JX; Xu J; Han F; Xiang S; Liu P; Chen HW; Wang J
Chem Biol Interact; 2020 Feb; 317():108965. PubMed ID: 32001260
[TBL] [Abstract][Full Text] [Related]
39. Transcription repression activity is associated with the type I isoform of the MMSET gene involved in t(4;14) in multiple myeloma.
Todoerti K; Ronchetti D; Agnelli L; Castellani S; Marelli S; Deliliers GL; Zanella A; Lombardi L; Neri A
Br J Haematol; 2005 Oct; 131(2):214-8. PubMed ID: 16197452
[TBL] [Abstract][Full Text] [Related]
40. NSD2 as a Promising Target in Hematological Disorders.
Azagra A; Cobaleda C
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
